6550 Reagents Consumables Microbiology Testing Boise VAMC
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
260-NETWORK CONTRACT OFFICE 20 (36C260)
Contract Value
Not provided
Codes & Classification
Solicitation Number
36C26027Q0117
NAICS
325413 - In-Vitro Diagnostic Substance Manufacturing
Classification Code
6550
Additional Details
Documents3
The Department of Veterans Affairs, through its 260-Network Contract Office 20, is conducting a sources sought inquiry to identify qualified vendors capable of providing a high-throughput, FDA-approved molecular diagnostic testing system and associated reagents for the Boise VA Medical Center (VAMC) in Idaho. This procurement is structured as a rental purchase agreement, enabling the facility to access advanced diagnostic technology while maintaining flexibility in acquiring additional specific products as needed throughout the year.
The primary objective of this procurement is to support rapid syndromic infectious disease diagnostic panels, which are critical for timely and accurate patient care within the VAMC. The selected system must be capable of high-throughput molecular testing, ensuring efficient processing of samples and reliable detection of a broad range of infectious agents. The scope of work includes not only the provision of the diagnostic instrument but also a steady supply of compatible reagents and consumables necessary for ongoing operations.
Key requirements for prospective contractors include the ability to supply an FDA-approved molecular diagnostic platform suitable for high-volume clinical use, as well as a comprehensive catalog of reagents tailored for syndromic infectious disease panels. The procurement falls under NAICS code 325413 (In-Vitro Diagnostic Substance Manufacturing), with Product Service Code 6550, and is not subject to any set-aside restrictions, making it open to all qualified vendors.
The place of performance is Idaho, specifically serving the Boise VAMC, with all deliverables and services to be provided within the United States. The contracting activity is managed by the 260-Network Contract Office 20, a federal office under the Department of Veterans Affairs. Interested parties are encouraged to review the opportunity details and submit their responses by November 28, 2026.
For further information or to express interest, contractors may contact Eric A. Lingenfelter at [email protected] or by phone at 360-852-9891. Additional details and attachments related to this opportunity can be accessed via the official SAM.gov listing at https://sam.gov/opp/b6d17aea5ceb4b8d988004142043a40b/view.
This sources sought notice represents an important opportunity for suppliers specializing in molecular diagnostic systems and reagents to support the VA’s mission of delivering high-quality healthcare to veterans. Contractors with proven capabilities in in-vitro diagnostic substance manufacturing and experience with federal healthcare procurement are particularly encouraged to respond.